These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16780845)

  • 1. Dual role of infections as risk factors for coronary heart disease.
    Pesonen E; Andsberg E; Ohlin H; Puolakkainen M; Rautelin H; Sarna S; Persson K
    Atherosclerosis; 2007 Jun; 192(2):370-5. PubMed ID: 16780845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-binding lectin as a risk factor for acute coronary syndromes.
    Pesonen E; Hallman M; Sarna S; Andsberg E; Haataja R; Meri S; Persson K; Puolakkainen M; Ohlin H; Truedsson L
    Ann Med; 2009; 41(8):591-8. PubMed ID: 19711212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
    el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
    Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].
    Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G
    Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease.
    Heltai K; Kis Z; Burian K; Endresz V; Veres A; Ludwig E; Gönczöl E; Valyi-Nagy I
    Atherosclerosis; 2004 Apr; 173(2):339-46. PubMed ID: 15064111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes.
    Biasucci LM; Liuzzo G; Ciervo A; Petrucca A; Piro M; Angiolillo DJ; Crea F; Cassone A; Maseri A
    Circulation; 2003 Jun; 107(24):3015-7. PubMed ID: 12796125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease.
    Ciervo A; Visca P; Petrucca A; Biasucci LM; Maseri A; Cassone A
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):66-74. PubMed ID: 11777831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study.
    Siscovick DS; Schwartz SM; Corey L; Grayston JT; Ashley R; Wang SP; Psaty BM; Tracy RP; Kuller LH; Kronmal RA
    Circulation; 2000 Nov; 102(19):2335-40. PubMed ID: 11067785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk.
    Huittinen T; Leinonen M; Tenkanen L; Mänttäri M; Virkkunen H; Pitkänen T; Wahlström E; Palosuo T; Manninen V; Saikku P
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):431-7. PubMed ID: 11884286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of antibodies to heat-shock proteins in ischemic heart disease.
    Hoymans VY; Bosmans JM; Van Herck PL; Ieven MM; Vrints CJ
    Int J Cardiol; 2008 Jan; 123(3):277-82. PubMed ID: 17383754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
    Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infectious exanthemas].
    Grundler E
    ZFA (Stuttgart); 1977 Jan; 53(3):164-8. PubMed ID: 320776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris].
    Bauriedel G; Andrié R; Likungu JA; Welz A; Braun P; Welsch U; Lüderitz B
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1408-13. PubMed ID: 10605420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to the 60-kDa heat-shock protein of Chlamydia pneumoniae in patients with coronary artery disease.
    Jantos CA; Krombach C; Wuppermann FN; Gardemann A; Bepler S; Asslan H; Hegemann JH; Haberbosch W
    J Infect Dis; 2000 May; 181(5):1700-5. PubMed ID: 10823771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.
    Altannavch Ts; Roubalová K; Broz J; Hrubá D; Andĕl M
    Cent Eur J Public Health; 2003 Jun; 11(2):102-6. PubMed ID: 12884557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age at childhood infections and risk of atopy.
    Bager P; Westergaard T; Rostgaard K; Hjalgrim H; Melbye M
    Thorax; 2002 May; 57(5):379-82. PubMed ID: 11978910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
    Wong BY; Gnarpe J; Teo KK; Ohman EM; Prosser C; Gibler WB; Langer A; Chang WC; Armstrong PW
    Am Heart J; 2002 Dec; 144(6):987-94. PubMed ID: 12486422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae seropositivity and risk of developing coronary heart disease in Western Saudi Arabia.
    Momenah AM; Tayeb MT
    Saudi Med J; 2005 Dec; 26(12):1926-9. PubMed ID: 16380774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.